Nuvalent, Inc.

NASDAQ:NUVL

76.66 (USD) • At close March 18, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Revenue 000000
Cost of Revenue 000000
Gross Profit 000000
Gross Profit Ratio 000000
Reseach & Development Expenses 217.774113.24363.73135.55915.4039.746
General & Administrative Expenses 62.59436.24922.37710.2581.5020.612
Selling & Marketing Expenses 000000
SG&A 62.59436.24922.37710.2581.5020.612
Other Expenses 004.254-0.5212.349-1.451
Operating Expenses 280.368149.49286.10845.81716.90510.358
Operating Income -280.368-149.492-86.108-45.817-16.905-10.358
Operating Income Ratio 000000
Total Other Income Expenses Net 20.37623.2734.254-0.5212.349-1.451
Income Before Tax -259.992-126.219-81.854-46.338-14.556-11.809
Income Before Tax Ratio 000000
Income Tax Expense 0.7640-8.508-0.237-0.017-0.01
Net Income -260.756-126.219-73.346-46.338-14.556-11.809
Net Income Ratio 000000
EPS -3.93-2.17-1.48-0.96-0.3-0.24
EPS Diluted -3.93-2.17-1.48-0.96-0.3-0.24
EBITDA -280.368-126.219-86.108-45.8172.349-1.451
EBITDA Ratio 000000